The bioengineering technology market size has grown rapidly in recent years. It will grow from $320.38 billion in 2024 to $361.95 billion in 2025 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to increasing aging population, increasing prevalence of chronic diseases, bioengineering technology market growth, favorable government initiatives, growing genetic engineering strategies.
The bioengineering technology market size is expected to see rapid growth in the next few years. It will grow to $591.25 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increased focus on cell therapies, rapid growth of synthetic biology, precision medicine advancements, increasing application in agriculture, expanded use in environmental solutions. Major trends in the forecast period include advanced gene editing techniques, convergence of technologies, advancements in precision medicine, global collaboration and partnership, synthetic biology applications.
The rising prevalence of chronic diseases is expected to drive the growth of the bioengineering technology market in the coming years. Chronic diseases are long-term health conditions marked by their persistent and ongoing nature. Bioengineering technology plays a crucial role in managing and treating these diseases, offering innovative solutions that improve patient outcomes and enhance quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the age-standardized death rate associated with chronic conditions was 448 per 100,000 population, increasing slightly to 459 per 100,000 in 2021, and rising further to 490 per 100,000 in 2022. As a result, the growing prevalence of chronic diseases is contributing to the expansion of the bioengineering technology market.
Key players in the bioengineering technology market are focusing on developing innovative technological products, such as Mito Plus, to advance the field of regenerative medicine. Mito Plus is a cutting-edge 3D bioprinter designed to produce tissues or organs resembling natural body parts, containing living cells, using 3D printing technology. For example, Avay Biosciences Pvt. Ltd., an India-based manufacturer and service provider of 3D printers, introduced Mito Plus in November 2022. This state-of-the-art bioprinter is hailed as one of the most advanced in its price range, capable of printing a wide range of biomaterials and featuring built-in UV curing options. It also incorporates HEPA filters and temperature control, enabling cooling of the printhead and print bed by up to 4 degrees Celsius, as well as heating capabilities.
In March 2023, Ginkgo Bioworks, a US-based horizontal platform for cell programming, acquired FGen AG for an undisclosed sum. This acquisition strengthens Ginkgo's position as a leader in the bioengineering field, providing it with a robust tool for strain development and optimization across various industries. FGen AG is a Switzerland-based bioengineering company.
Major companies operating in the bioengineering technology market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Moderna Inc., Becton Dickinson (BD), Regeneron Pharmaceuticals, Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Agilent Technologies, Lonza Group Ltd., Intuitive Surgical, Illumina, Inc., Bio-Rad Laboratories, Ginkgo Bioworks, Verve Therapeutics, Inc., CRISPR Therapeutics.
North America was the largest region in the bioengineering technology market in 2024. The regions covered in the bioengineering technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioengineering technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioengineering technology market includes revenues earned by entities service such as medical diagnostic services, pharmaceutical services, personalized medicine services, engineering, and nanotechnology in medicine services, biological data analysis services, regenerative medicine services, and health information technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The bioengineering technology market consists of sales of implantable medical devices, wearable health monitoring devices, biomedical imaging equipment, and diagnostic devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
Bioengineering technology involves applying principles and techniques from engineering and the natural sciences to develop technologies and solutions for understanding, manipulating, and utilizing biological systems, particularly in the fields of medicine, biology, and healthcare.
The primary types of products in bioengineering technology include biomedical engineering, genetic engineering, biotechnology, tissue engineering, biomechanics engineering, biomaterials, nano-biotechnology, bioinformatics, and others. Biomedical engineering entails applying engineering principles and design concepts to medicine and biology for healthcare purposes. It encompasses various technologies such as nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, and fermentation, and finds applications in health, food and agriculture, natural resources, and the environment.
The bioengineering technology market research report is one of a series of new reports that provides bioengineering technology market statistics, including bioengineering technology industry global market size, regional shares, competitors with a bioengineering technology market share, detailed bioengineering technology market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineering technology industry. This bioengineering technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Bioengineering Technology Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on bioengineering technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bioengineering technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioengineering technology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Biomedical Engineering; Genetic Engineering; Biotechnology; Tissue Engineering; Biomechanics Engineering; Biomaterial; Biomechanical Engineering; Nano-Biotechnology; Bioinformatics; Other Products2) By Technology: Nanobiotechnology; Tissue Engineering And Regeneration; DNA Sequencing; Cell-Based Assays; Fermentation
3) By Application: Health; Food And Agriculture; Natural Resources And Environment
Subsegmnets:
1) By Biomedical Engineering: Medical Devices; Diagnostic Equipment; Prosthetics And Implants2) By Genetic Engineering: Gene Editing Tools (CRISPR); Recombinant DNA Technology; Gene Therapy Products
3) By Biotechnology: Biopharmaceuticals; Industrial Biotechnology Products; Agricultural Biotechnology
4) By Tissue Engineering: Scaffolds; Stem Cell Technology; Regenerative Medicine Products
5) By Biomechanics Engineering: Motion Analysis Systems; Orthopedic Biomechanics; Sports Biomechanics Products
6) By Biomaterials: Natural Biomaterials; Synthetic Biomaterials; Biodegradable Polymers
7) By Biomechanical Engineering: Prosthetic Devices; Orthotic Devices; Rehabilitation Equipment
8) By Nano-Biotechnology: Nanoparticles For Drug Delivery; Nanosensors; Nanomaterials For Biomedical Applications
9) By Bioinformatics: Genomic Data Analysis Tools; Protein Structure Analysis Software; Biological Databases
10) By Other Products: Environmental Bioengineering Solutions; Bioremediation Technologies; Bioprocessing Equipment.
Key Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Novartis AG; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Bioengineering Technology market report include:- Pfizer Inc.
- Johnson & Johnson
- Roche Holding AG
- Novartis AG
- Bristol-Myers Squibb Company
- Thermo Fisher Scientific
- Abbott Laboratories
- AstraZeneca plc
- Medtronic plc
- Gilead Sciences Inc.
- Amgen Inc.
- Novo Nordisk A/S
- Moderna Inc.
- Becton Dickinson (BD)
- Regeneron Pharmaceuticals, Inc.
- Biogen Inc.
- Vertex Pharmaceuticals Inc.
- Agilent Technologies
- Lonza Group Ltd.
- Intuitive Surgical
- Illumina, Inc
- Bio-Rad Laboratories
- Ginkgo Bioworks
- Verve Therapeutics, Inc.
- CRISPR Therapeutics
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | March 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 361.95 Billion |
Forecasted Market Value ( USD | $ 591.25 Billion |
Compound Annual Growth Rate | 13.1% |
Regions Covered | Global |
No. of Companies Mentioned | 26 |